BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 30026170)

  • 1. Concentration-dependent plasma protein binding: Expect the unexpected.
    Nation RL; Theuretzbacher U; Tsuji BT;
    Eur J Pharm Sci; 2018 Sep; 122():341-346. PubMed ID: 30026170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measurement and analysis of unbound drug concentrations.
    Wright JD; Boudinot FD; Ujhelyi MR
    Clin Pharmacokinet; 1996 Jun; 30(6):445-62. PubMed ID: 8792057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein binding in antiretroviral therapies.
    Boffito M; Back DJ; Blaschke TF; Rowland M; Bertz RJ; Gerber JG; Miller V
    AIDS Res Hum Retroviruses; 2003 Sep; 19(9):825-35. PubMed ID: 14585213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonlinear Protein Binding: Not What You Think.
    Deitchman AN; Singh RSP; Derendorf H
    J Pharm Sci; 2018 Jul; 107(7):1754-1760. PubMed ID: 29626534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The bioanalytical challenge of determining unbound concentration and protein binding for drugs.
    Nilsson LB
    Bioanalysis; 2013 Dec; 5(24):3033-50. PubMed ID: 24320129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of concentration-dependent binding to plasma proteins on the pharmacokinetics and pharmacodynamics of disopyramide.
    Giacomini KM; Blaschke TF
    Clin Pharmacokinet; 1984 Jan; 9 Suppl 1():42-8. PubMed ID: 6705426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic elimination of drugs with concentration-dependent serum protein binding.
    Huang JD; Oie S
    J Pharmacokinet Biopharm; 1984 Feb; 12(1):67-81. PubMed ID: 6747819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Importance of protein binding for the interpretation of serum or plasma drug concentrations.
    Greenblatt DJ; Sellers EM; Koch-Weser J
    J Clin Pharmacol; 1982; 22(5-6):259-63. PubMed ID: 7107972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do we need to optimize plasma protein and tissue binding in drug discovery?
    Liu X; Chen C; Hop CE
    Curr Top Med Chem; 2011; 11(4):450-66. PubMed ID: 21320069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calculation of normalized drug concentrations in the presence of altered plasma protein binding.
    Musteata FM
    Clin Pharmacokinet; 2012 Jan; 51(1):55-68. PubMed ID: 22149258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On the possibility of self-induction of drug protein binding.
    Berezhkovskiy LM
    J Pharm Sci; 2010 Oct; 99(10):4400-5. PubMed ID: 20737641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age-related changes in protein binding of drugs: implications for therapy.
    Grandison MK; Boudinot FD
    Clin Pharmacokinet; 2000 Mar; 38(3):271-90. PubMed ID: 10749520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pH dependency of the binding of drugs to plasma proteins in man.
    Hinderling PH; Hartmann D
    Ther Drug Monit; 2005 Feb; 27(1):71-85. PubMed ID: 15665750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of unbound drug concentration and protein-drug binding fraction in plasma.
    Liu Z; Li F; Huang Y
    Biomed Chromatogr; 1999 Jun; 13(4):262-6. PubMed ID: 10416057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma/serum protein binding determinations.
    Banker MJ; Clark TH
    Curr Drug Metab; 2008 Nov; 9(9):854-9. PubMed ID: 18991581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An extended pharmacokinetic/pharmacodynamic model describing quantitatively the influence of plasma protein binding, tissue binding, and receptor binding on the potency and time course of action of drugs.
    Proost JH; Wierda JM; Meijer DK
    J Pharmacokinet Biopharm; 1996 Feb; 24(1):45-77. PubMed ID: 8827583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of atypical nonlinear plasma−protein-binding behavior of tigecycline using an in vitro microdialysis technique.
    Mukker JK; Singh RP; Derendorf H
    J Pharm Sci; 2014 Mar; 103(3):1013-9. PubMed ID: 24549736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methods of determining plasma and tissue binding of drugs. Pharmacokinetic consequences.
    Pacifici GM; Viani A
    Clin Pharmacokinet; 1992 Dec; 23(6):449-68. PubMed ID: 1458763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma protein binding: from discovery to development.
    Bohnert T; Gan LS
    J Pharm Sci; 2013 Sep; 102(9):2953-94. PubMed ID: 23798314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Blood plasma proteins and drug transport across the hemato-encephalic barrier].
    Lutsevich AN; Bender KI; Kupchikov VV
    Farmakol Toksikol; 1991; 54(1):70-6. PubMed ID: 1860509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.